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Abstract
The Bacillus cereus group of bacteria includes seven closely related species, three of
which, B. anthracis, B. cereus and B. thuringiensis, are pathogens of humans, animals and/
or insects. Preliminary investigations into the transport capabilities of different bacterial line-
ages suggested that genes encoding putative efflux systems were unusually abundant in
the B. cereus group compared to other bacteria. To explore the drug efflux potential of the
B. cereus group all putative efflux systems were identified in the genomes of prototypical
strains of B. cereus, B. anthracis and B. thuringiensis using our Transporter Automated
Annotation Pipeline. More than 90 putative drug efflux systems were found within each of
these strains, accounting for up to 2.7% of their protein coding potential. Comparative analy-
ses demonstrated that the efflux systems are highly conserved between these species; 70–
80% of the putative efflux pumps were shared between all three strains studied. Further-
more, 82% of the putative efflux system proteins encoded by the prototypical B. cereus
strain ATCC 14579 (type strain) were found to be conserved in at least 80% of 169 B. cereus
group strains that have high quality genome sequences available. However, only a handful
of these efflux pumps have been functionally characterized. Deletion of individual efflux
pump genes from B. cereus typically had little impact to drug resistance phenotypes or the
general fitness of the strains, possibly because of the large numbers of alternative efflux
systems that may have overlapping substrate specificities. Therefore, to gain insight into the
possible transport functions of efflux systems in B. cereus, we undertook large-scale qRT-
PCR analyses of efflux pump gene expression following drug shocks and other stress treat-
ments. Clustering of gene expression changes identified several groups of similarly regu-
lated systems that may have overlapping drug resistance functions. In this article we review
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current knowledge of the small molecule efflux pumps encoded by the B. cereus group and
suggest the likely functions of numerous uncharacterised pumps.
Introduction
The Bacillus cereus group is composed of seven species of low G+C Gram-positive spore-form-
ing bacteria, which based on 16S rRNA sequence data form a separate cluster in the phyloge-
netic tree of Bacillaceae and Firmicutes [1]. The B. cereus group includes B. cereus (sensu
stricto), B. anthracis, and B. thuringiensis, which are all well studied and are pathogens of ani-
mals, humans or insects, as well as B. weihenstephanensis, B. mycoides, B. pseudomycoides and
B. cytotoxicus. The different species can commonly, but with variable frequency, be found in
the soil environment, and can thus constitute polluter organisms in food production facilities
and dairies, as well as in hospitals [2, 3]. Bacteria within the B. cereus group have also been sug-
gested to naturally inhabit the insect gut [4].
The pathogenic species of the B. cereus group have different host preferences, mainly due to
traits encoded on plasmids. B. anthracis is the cause of anthrax, primarily an animal disease
but also occasionally of humans, due to its production of anthrax-specific toxins (lethal and
edema toxins) and a poly-γ-D-glutamate capsule which provides protection against the host
immune system. B. anthracis is endemic in several parts of the world [5]. The three toxin genes
(pag, lef and cya) are located on a plasmid, pXO1 (189 kb), while the genes necessary for cap-
sule synthesis, capABCD, are located on plasmid pXO2 (95 kb), and fully virulent B. anthracis
strains carry both plasmids. B. cereus sensu stricto (here called B. cereus) is an opportunistic
pathogen capable of causing a range of diseases [2, 6], most prominently foodborne disease
due to the production of enterotoxins (diarrhoeal syndrome) or a non-ribosomally synthesized
dodecadepsipeptide toxin (emetic syndrome). The emetic toxin is encoded by genes on a large
270 kb plasmid, pCER270 [7, 8]. Interestingly, B. cereus strains causing anthrax-like disease
were isolated from welders in the US and shown to carry a plasmid highly similar to pXO1 [9],
as well as from African great apes (Cameroon, Ivory Coast), shown to carry full pXO1 and
pXO2 virulence plasmids [10, 11]. B. thuringiensis strains produce proteinaceous crystal toxins
(Cry or Cyt toxin) during sporulation which are the primary cause of their toxicity toward
insects, and which are encoded by genes most often located on plasmids. B. thuringiensis
strains do however, also carry the chromosomal enterotoxin genes found in B. cereus, and the
two species are genetically indistinguishable based on chromosomal characters [12, 13]. Many
of the chromosomally encoded virulence factors in B. cereus and B. thuringiensis are positively
regulated at the transcriptional level by the PlcR-PapR peptide-based quorum sensing system.
The plcR gene is also present in B. anthracis strains, but carries a deleterious mutation making
the protein non-functional and leaving the PlcR regulated genes non-transcribed [14].
Given that different species within the B. cereus group have diverse toxic effects and host
specificities, but are closely related at the phylogenetic level, their intra- and inter-species
diversity has frequently been studied at the genome level. Large-scale sequencing studies of B.
cereus group strains have allowed the calculation of a core genome of genes shared between all
strains (aproximately 1750 genes), and a set of additional genes found in almost every genome,
constituting the extended core (approximately 2150 genes) [15]. The B. cereus group core
genome appears to harbour a high number of genes encoding transporter proteins. This may
reflect the fact that B. cereus group bacteria are frequently found in environments such as soil,
which display high variability with respect to potential nutrients and exposure to toxic
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chemicals, including antibiotics and other antimicrobial agents. Putative efflux pumps appear
to be particularly common within the genomes of the B. cereus group but relatively few of
these transporters have been functionally characterised to date. In contrast, the model organ-
ism Bacillus subtilis encodes some of the best characterised multidrug efflux pumps in bacteria,
including the related Bmr and Blt transporters from the major facilitator superfamily [16–18].
Bacterial drug efflux pumps generally fall into one of five families or superfamilies of trans-
port proteins, the major facilitator superfamily (MFS), the ATP binding cassette (ABC) super-
family, the resistance/nodulation/division (RND) superfamily, the multidrug and toxic
compound extrusion (MATE) family and the small multidrug resistance superfamily (SMR).
A sixth family of multidrug efflux pumps, the Proteobacterial antimicrobial compound extru-
sion (PACE) family was recently identified [19, 20]. However, genes encoding PACE family
proteins have been identified in the genome sequences of a small number of species outside
the Proteobacteria.
Here we describe the putative efflux pumps carried by B. cereus group isolates that fall
within each of the five major families of transport proteins. The number of pumps, their puta-
tive substrates and conservation across the group is described, followed by a detailed review of
the efflux systems encoded by the B. cereus type strain, ATCC 14579. The transcriptional
responses of selected conserved pumps encoded by this strain to a panel of structurally and
mechanistically diverse drugs or stress conditions were determined to gain insight into their
potential functional roles.
Methods
Bioinformatics analyses
Transport proteins encoded within the genomes of B. cereus ATCC 14579, B. anthracis Ames
and B. thuringiensis konkukian 97–27, were identified using the Transporter Automated
Annotation Pipeline (TransAAP) [21]. This pipeline predicts the complete complement of
transporters encoded by an organism based on the annotated amino acid sequences within its
genome sequence by running a variety of searches including BLASTP (to the Transporter Clas-
sification Database—TCDB, TransAAP and GenBank databases), HMM, Pfam, TIGRfam
HMM and COG searches, as well as other analyses such as TMHMM hydropathy prediction
[21]. Efflux proteins were identified in the TransAAP output and manually curated for a likely
role in the efflux of drugs or small molecules.
To broadly examine the conservation of putative efflux systems between the B. cereus type
strain ATCC 14579 and other strains within the B. cereus group, we conducted reciprocal best-
match BLASTP 2.2.28+ analyses. Searches between all CDSs annotated in the ATCC 14579
genome and 168 other B. cereus group strains listed in the RefSeq database with assembly level
“complete” or “chromosome” (August 2016; S1 Table) were executed through the Protei-
northo tool [22]. Putative orthologs/paralogs were identified as reciprocal best-match BLASTP
hits that recorded an e-value below 1e-50, and greater than 50% coverage. Since these analyses
used annotated amino acid sequences as input, no pseudogenes were analysed.
Antimicrobial exposure, stress treatments and RNA isolation
Minimum inhibitory concentrations (MIC) towards B. cereus ATCC 14579 for chlorampheni-
col, kanamycin, erythromycin, tetracycline, and ethidium bromide were previously deter-
mined [23], and MIC values for norfloxacin, 2,2’-dipyridyl, tannic acid, Dominulin B and a
crude ethanol surface extract of a social paper wasp, Polistes humilis [24], were determined
using the same method.
Efflux systems of the Bacillus cereus group
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MH broth was inoculated with a 1% inoculum of an overnight culture of B. cereus ATCC
14579 and grown at 30˚C with shaking to an OD600 of approximately 0.8. The culture was then
diluted in MH broth to OD600 = 0.1, and grown as before to an OD600 of approximately 0.8.
The culture was then split and the compound (or crude wasp ethanol extract) used for antimi-
crobial exposure treatment was added at a concentration equivalent to 50% of the respective
MIC to separate cultures. An untreated culture was included as a control. The cultures were
further grown for 20 minutes. Bacterial cells were harvested by incubating cultures in an equal
volume of ice-cold methanol for 5 minutes before centrifugation at 4000 x g for 5 minutes. Pel-
lets were stored at -80˚C.
For extraction of RNA, cells were lysed using Lysing Matrix B and a FastPrep instrument
(both MP Biomedicals), and RNA was isolated using the PureLink RNA Mini Kit (Invitrogen)
or the RNeasy Mini Kit (Qiagen). RNA was treated with TURBO DNase (Ambion) as
described, followed by a second round of purification using one of the RNA Mini Kits. RNA
concentration and purity were measured using a NanoDrop ND-1000 spectrophotometer.
Quantitative reverse transcription PCR (qRT-PCR)
cDNA synthesis was performed in duplicate for each RNA sample, using the SuperScript
VILO cDNA Synthesis Kit (Invitrogen) or the Quantitect cDNA synthesis Kit (QIAGEN) and
respective protocols, with 1μg RNA. qPCR reactions were performed on a MasterCycler real-
plex4 (Eppendorf) in a 96-well microtiterplate format and a final volume of 5μl using 1μl
cDNA diluted 1:20, 2.5μl 2×GoTaq qPCR master mix (Promega) and 0.2μM of each primer. In
qPCR experiments studying gene expression in cells exposed to wasp ethanol extract or Domi-
nulin B, qPCR was performed in 200 ul thin-walled tubes and a final volume of 10μl, using
5.0μl 2×GoTaq qPCR master mix. Cycling conditions were 95˚C for 2 minutes followed by 40
cycles at 95˚C for 10 seconds, 55˚C for 10 seconds, and 68˚C for 8 seconds, followed by a melt-
ing curve analysis, which resulted in single product specific melting temperatures for all sam-
ples. Control qPCR reactions using DNase-treated RNA diluted to 0.005μg/μl as the template
confirmed the absence of amplification of contaminating DNA.
Conserved putative MDR efflux pumps were selected for qPCR analysis after the stress
treatments. After one round of qPCR only those conserved MFS and ABC genes that showed
above 3-fold differential expression in at least one of the stress conditions were included in the
further qPCR analysis (13 MFS and 6 ABC). In addition all the efflux pumps belonging to the
RND, SMR and MATE families were included (three or four from each family).
The BC1744 helicase gene was selected for use as the reference gene. The list of primers
used is given in S2 Table. For gene expression analysis, the quantification cycle (Cq) values
were determined using the realplex software (Eppendorf). Cq values were transformed into
linear scale expression quantities using the formula ECq [25]. The expression of each target
gene was normalized to that obtained for the helicase reference gene reaction run on the same
plate. Then, for each target gene, the expression ratio between the untreated and antimicrobial
treated samples was calculated (ΔΔ-Cq-method) [25] and finally the values obtained for the
two technical replicates were averaged.
Biofilm formation
The biofilm forming capabilities of B. cereus ATCC 14579 wild type and isogenic markerless
gene deletion mutant strains were investigated with a microplate screening assay modified
from a previously described method [26]. Precultures were grown in Y1 minimal medium [27]
at 3˚C to early exponential growth (optical density at 600 nm (OD600) ~ 0.3) and were then
used to inoculate fresh Y1 medium to an OD600 of 0.01. For each strain, sixteen wells of a
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96-well polystyrene microplate (Corning 3788) were filled with 125 μl of the bacterial suspen-
sion. The plates were produced in duplicate and each plate contained eight wells of Y1 medium
as a negative control. Following incubation at 20˚C for 48 h and 72 h, respectively, the wells of
each microplate were washed once with phosphate-buffered saline (PBS) and stained with a
0.1% (w/v) aqueous solution of methyl violet 6B for 30 min at room temperature. Wells were
then washed three times with PBS and dried upside down over night. To quantify biofilm for-
mation the dye was solubilized by incubating the wells with 150 μl of a 1:4 acetone/ethanol
mixture for 10 min at room temperature, and subsequently absorbance at 570 nm was
determined.
Results and discussion
Putative drug efflux systems are highly represented and well conserved
in the Bacillus cereus group
To define the efflux potential of the B. cereus group, putative efflux systems were identified in
the complete genome sequences of three reference strains, B. cereus ATCC 14579, B. anthracis
Ames and B. thuringiensis konkukian 97–27, using the transporter automated annotation pipe-
line (TransAAP) [21]. These analyses identified 93, 93 and 103 putative efflux systems in these
strains, respectively (Table 1). Remarkably, these efflux systems account for 2.3 to 2.7% of the
predicted protein coding potential in these strains (Table 1). The majority of the efflux systems
identified were classified within the MFS (greater than 50 pumps in all three strains) or ABC
superfamily (28 to 35 transport systems), with only 3 to 5 efflux pumps from each of the RND,
MATE and SMR (super)families (Table 1). For comparison, the numbers of putative efflux
pumps encoded within the genomes of eight other representative bacterial strains within the
Firmicutes were determined, including human and animal pathogens, and soil isolates that
have similar lifestyles to the B. cereus group strains (Table 1). None of the other Firmicutes
encoded as many putative efflux pumps as the B. cereus group isolates. However, the Listeria
species examined, which have smaller genomes than strains in the B. cereus group, devoted a
similar proportion of their protein coding potential to the production of transport proteins
that may function in drug efflux as the B. cereus group strains (Table 1). These results suggest
that strains in the B. cereus group have very high drug and/or small molecule efflux potential.
Table 1. Numbers of putative drug efflux systems encoded in the genomes of reference strains of the B. cereus group, and other Firmicutes.
Strain ABC MFS MATE SMR RND Totalb % ORFs
Bacillus anthracis Ames 28a 51 4 5 4 93 2.3
Bacillus cereus ATCC 14579 28 53 4 4 3 93 2.3
Bacillus thuringensis konkukian 97–27 35 53 4 5 5 103 2.7
Bacillus megaterium QMB1551 30 40 4 4 6 84 1.7
Bacillus pumilus SAFR032 23 30 4 3 4 64 2.0
Bacillus subtilis 168 20 39 4 4 4 71 2.0
Staphylococcus aureus N315 16 22 1 1 2 42 1.8
Clostridium perfringens ATCC 13124 16 8 10 0 1 35 1.5
Listeria monocytogenes La111 27 23 9 1 3 63 2.7
Listeria innocua Clip11262 31 18 6 1 2 58 2.4
Geobacillus thermodenitrificans NG802 20 11 2 2 3 38 1.5
a. Transporters were identified using the Transporter Automated Annotation Pipeline and are listed at www.membranetransport.org.
b. Total number of transport systems. Some ABC and SMR (super)family systems are comprised of several proteins.
https://doi.org/10.1371/journal.pone.0176188.t001
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To examine the level of conservation of the putative efflux systems in B. cereus ATCC
14579, B. anthracis Ames and B. thuringiensis konkukian 97–27, their predicted proteomes
were compared using reciprocal best-match BLASTP searches. These searches suggested that
75 of the putative efflux systems were conserved in all three strains, representing 81% of those
encoded in the B. anthracis Ames and B. cereus ATCC 14579 genomes (Fig 1A). To further
explore the conservation of efflux systems in the B. cereus group, we examined the level of con-
servation of the B. cereus ATCC 14579 efflux pumps in 168 other B. cereus group strains with
available high-quality genome sequences (S1 Table). This analysis suggested that 21 putative
efflux proteins (components of 16 different efflux systems) encoded by B. cereus ATCC 14579
were conserved in all 168 strains (Fig 1B). Furthermore, 82% of the putative efflux system pro-
teins in B. cereus ATCC 14579 were conserved in at least 80% of the strains examined (Fig 1B).
These highly conserved putative efflux pumps are likely to have important core functions, pos-
sibly related to the basic physiology of the cell. The most poorly conserved transport systems
were classified within the MFS or ABC superfamily (Fig 1B). However as mentioned above
there are large numbers of these transporters encoded in B. cereus group genomes. Complete
sets of putative transport proteins, including efflux pumps, encoded in the genomes of B.
cereus group strains are listed in the TransportDB database [21].
Major facilitator superfamily efflux pumps encoded in B. cereus ATCC
14579
The major facilitator superfamily (MFS) of transport proteins is an ancient protein family
found in all classes of living organisms. MFS proteins participate in a broad range of transport
reactions including the uptake of essential nutrients and the efflux of toxic compounds. Uptake
and efflux pumps can be differentiated based on the presence of several key amino acid
sequence motifs [28], such as sequence motif C which may be involved in the proton:substrate
antiport coupling reaction [29]. The majority of bacterial drug efflux pumps classified within
the MFS, are found within one of three transporter families, the drug:H+ antiport (DHA) 1–3
families, however, several other families are known or predicted to include drug efflux pumps.
Proteins classified within the DHA1 and DHA3 families are typically organised into 12 trans-
membrane segments, similar to the majority of MFS pumps, whereas, those within the DHA2
Fig 1. Conservation of putative efflux systems encoded in the Bacillus cereus group. (A) Venn diagram
showing conservation of putative efflux systems in fully sequenced representatives of the B. cereus group. (B)
Conservation of genes encoding efflux system components in B. cereus ATCC 14579. Reciprocal BLASTP
2.2.28+ searches (as executed through the Proteinortho tool [22]) of the B. cereus ATCC 14579 predicted
proteome with 168 other strains in the B. cereus group (S1 Table) were used to determine the level of
conservation. Each transporter component is represented by a single box, the size and shading of which
corresponds to its conservation. Panel B was generated using TreeMap version 4.1.
https://doi.org/10.1371/journal.pone.0176188.g001
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family are typically organised into 14 transmembrane segments. DHA1 and DHA2 family pro-
tein sequences are more common in sequence databases and are encoded by both Gram-posi-
tive and Gram-negative bacteria, whereas, DHA3 family proteins are principally encoded by
Gram-positives.
The genome of B. cereus ATCC 14579 encodes 53 putative MFS family drug efflux pumps.
Thirty-eight of these transporters were predicted to fall within the DHA1, DHA2 or DHA3
families, 16, 12 and 10 proteins, respectively, based on BLASTP comparisons to all MFS pro-
teins within the TCDB [30] (Table 2). The best hits for the remaining 15 putative B. cereus
MFS efflux pumps were to three of the unknown major facilitator families (UMF2, UMF5 and
UMF11), the nickel resistance (Nre) family, the putative aromatic compound/drug exporter
(ACDE) family and the acriflavin-sensitivity (YnfM) family. Transporters within each of these
families are known or predicted to function in the efflux of antimicrobial drugs.
Several MFS drug resistance efflux pumps have been previously characterised in B. cereus,
including two members of the DHA2 family. The first of these, RZC03923 (orthologous to
BC0962 in ATCC 14579) was cloned from B. cereus BRL1244, is similar to LmrB in B. subtilis
and was characterised as part of a study examining the homologous DHA2 pump MdeA in S.
aureus [31]. This pump was shown to confer resistance to virginiamycin, erythromycin, and
lincomycin [31]. The second DHA2 family pump from B. cereus to be examined functionally,
BC4707 from B. cereus ATCC 14579, was identified due to its increased expression in response
to bile salts [32] and was found to facilitate resistance to norfloxacin, kanamycin and ciproflox-
acin, and thus functions as a multidrug efflux pump [23]. In addition to the DHA2 family, a
recent study by Kroeger et al. (2015) demonstrated that BC3310 encodes an active efflux pump
that confers resistance to ethidium bromide, SDS and silver nitrate [33]. The BC3310 pump is
the first protein from the UMF2 family of the MFS to have been studied experimentally, and
its resistance phenotypes confirmed that members of the UMF2 family function in drug efflux
[33].
Some B. cereus group MFS efflux pumps are likely to mediate the efflux of endogenously
produced secondary metabolites. For example, BC2310 is located in a gene cluster coding for
biosynthesis of bacillibactin [34], and is likely to mediate the efflux of this siderophore or a bio-
synthetic intermediate. BC2450 encodes an efflux pump that may transport a cyclic lipopep-
tide. Of the transporters listed in the TCDB, the BC2450 pump is most similar to the nickel
resistance (Nre) family pump KrsE encoded by B. cereus VD014 (99% identical) (Table 2). The
KrsE pump is encoded by the first gene in a large (~30 kb) six-gene cluster that includes several
non-ribosomal peptide synthase genes involved in the biosynthesis of a cyclic lipopeptide, kur-
stakin. The cluster is also found in ATCC 14579 [35], but may not be active in this strain, pos-
sibly partly due to a transposon insertion in this strain in the quorum sensing regulator gene,
nprR, which regulates production of kurstakin [36]. The role of KrsE in the efflux of kurstakin
lipopeptides is yet to be demonstrated in B. cereus group strains, but a recent study demon-
strated that an orthologous pump is involved in the efflux of a surfactin in B. subtilis [37]. Sur-
factin has been shown by a number of studies to be essential for formation of mature biofilms
by B. subtilis [38, 39].
Several putative B. cereus MFS efflux pumps were very similar to characterised multidrug
efflux pumps encoded by B. subtilis (e-value = 0; Table 2). These included the DHA1 family
pump BC0855 (74% identity, 86% similarity to Blt), and the DHA2 family pumps BC4000
(62% identity, 76% similarity to Bmr3), BC2880 (60% identity, 76% similarity to Bmr3) and
BC0658 (75% identity, 88% similarity to MdrP) (Table 2). Therefore, these B. cereus pumps
may also mediate multidrug resistance.
Blt of B. subtilis was first recognised as being a multidrug efflux pump able to confer resis-
tance to a range of substrates when overexpressed. Deletion of this gene from B. subtilis did
Efflux systems of the Bacillus cereus group
PLOS ONE | https://doi.org/10.1371/journal.pone.0176188 May 4, 2017 7 / 25
Table 2. Putative B. cereus ATCC 14579 MFS efflux pumps.
Locus
tag
Conservationa Best match name Function(s) of best match Top blastp hit(s)b,c
2.A.1.2—The Drug:H+ Antiporter-1 (12 Spanner) (DHA1) Family
BC0855* 97.6 Blt of Bacillus subtilis Multidrug (and spermidine) efflux P39843 2.A.1.2.8 (0); P33449 2.A.1.2.70 (6e-133);
P0A0J7 2.A.1.2.10 (3e-95)
BC4738 100.0 YttB of Bacillus subtilis Unknown O34546 2.A.1.2.69 (4e-152); P0A0J7 2.A.1.2.10
(4e-10); Q48658 2.A.1.2.5 (3e-06)
BC5012 99.4 PbuE of Bacillus subtilis Purine base/nucleoside efflux Q797E3 2.A.1.2.25 (8e-130); P77389 2.A.1.2.65
(1e-40); Q9S3J9 2.A.1.2.18 (5e-34)
BC1786* 97.0 MdtG of Escherichia coli Putative multidrug efflux P25744 2.A.1.2.20 (1e-122); P0A4K4 2.A.1.2.34
(7e-95); Q07282 2.A.1.2.75 (8e-18)
BC2402 42.6 TetA42 of Micrococcus sp.
SMCC G8878
Tetracycline resistance B2YGG2 2.A.1.2.41 (4e-72); P02982 2.A.1.2.4 (9e-
52); Q5JAK9 2.A.1.2.39 (1e-49)
BC3393 82.8 YdhP of Escherichia coli Unknown P77389 2.A.1.2.65 (1e-70); Q797E3 2.A.1.2.25 (3e-
57); P23910 2.A.1.2.14 (7e-54)
BC5058 98.2 YdhP of Escherichia coli Unknown P77389 2.A.1.2.65 (3e-70); Q797E3 2.A.1.2.25 (2e-
57); P23910 2.A.1.2.14 (5e-55)
BC3456 95.3 EmrD-3 of Vibrio cholerae Multidrug efflux Q9KMQ3 2.A.1.2.42 (1e-65); P32482 2.A.1.2.3 (4e-
26); Q7VW14 2.A.1.2.27 (2e-24)
BC0204 96.4 Bcr of Escherichia coli Multidrug (and L-cysteine) efflux P28246 2.A.1.2.7 (4e-65); Q7VW14 2.A.1.2.27 (7e-
39); P37597 2.A.1.2.62 (5e-37)
BC0860 87.6 LmrP of Lactococcus lactis Multidrug efflux Q48658 2.A.1.2.5 (8e-55); O34546 2.A.1.2.69 (2e-
15); P69367 2.A.1.2.21 (3e-15)
BC0256* 98.2 YdeE of Escherichia coli Peptide (and possibly arabinose)
exporter
P31126 2.A.1.2.55 (2e-20); B8GFY3 2.A.1.46.4 (1e-
20)
BC0667* 98.2 TetA41 of Serratia
marcescens
Tetracycline exporter Q5JAK9 2.A.1.2.39 (2e-17); Q56RY7 2.A.1.2.38
(2e-16); C2UR80 2.A.1.46.5 (1e-14)
BC3622 51.5 YdeE of Escherichia coli Peptide (and possibly arabinose)
exporter
P31126 2.A.1.2.55 (5e-22); O34546 2.A.1.2.69 (7e-
14); P69367 2.A.1.2.21 (2e-13)
BC2885 98.8 TetA42 of Micrococcus sp.
SMCC G8878
Tetracycline resistance B2YGG2 2.A.1.2.41 (5e-12); Q8NRB5 2.A.1.2.24
(1e-12); P31126 2.A.1.2.55 (3e-11)
BC0202 99.4 PmrA of Streptococcus
pneumoniae
Multidrug efflux P0A4K4 2.A.1.2.34 (5e-09); P25744 2.A.1.2.20 (1e-
07); H6LDK2 2.A.1.2.90 (1e-06)
BC2061 3.6 HsMDR of Halobacterium sp.
NRC-1
Multidrug resistance Q9HS33 2.A.1.2.47 (5e-06)
2.A.1.3—The Drug:H+ Antiporter-2 (14 Spanner) (DHA2) Family
BC4000* 98.8 Bmr3 of Bacillus subtilis Multidrug resistance P96712 2.A.1.3.50 (0); O32182 2.A.1.3.33 (1e-104);
Q9ZGB6 2.A.1.3.32 (9e-72)
BC2880 98.2 Bmr3 of Bacillus subtilis Multidrug resistance P96712 2.A.1.3.50 (0); O32182 2.A.1.3.33 (6e-101);
Q9ZGB6 2.A.1.3.32 (5e-66)
BC0658 99.4 MdtP of Bacillus subtilis Multidrug efflux O32182 2.A.1.3.33 (0); P96712 2.A.1.3.50 (6e-95);
Q9ZGB6 2.A.1.3.32 (1e-82)
BC0962 93.5 LmrB of Bacillus subtilis Lincomycin resistance O35018 2.A.1.3.30 (2e-164); Q7A3S4 2.A.1.3.61
(6e-109); Q5HE38 2.A.1.3.39 (7e-99)
BC3212* 95.9 LmrB of Bacillus subtilis Lincomycin resistance O35018 2.A.1.3.30 (6e-132); Q7A3S4 2.A.1.3.61
(7e-117); Q5HE38 2.A.1.3.39 (4e-111)
BC4568* 98.2 LmrB of Bacillus subtilis Lincomycin resistance O35018 2.A.1.3.30 (2e-106); Q5HE38 2.A.1.3.39
(4e-103); Q7A3S4 2.A.1.3.61 (7e-93)
BC0757 95.9 YvmA of Bacillus subtilis Unknown O34307 2.A.1.3.56 (3e-100); P37597 2.A.1.2.62
(8e-26); O31762 2.A.1.32.2 (3e-22)
BC4707* 98.8 Bmr3 of Bacillus subtilis Multidrug resistance P96712 2.A.1.3.50 (2e-82); O32182 2.A.1.3.33 (9e-
80); Q9ZGB6 2.A.1.3.32 (1e-64)
BC1757 46.2 EmrB of Escherichia coli Multidrug efflux P0AEJ0 2.A.1.3.2 (9e-45); O32182 2.A.1.3.33 (1e-
44); Q9RQ29 2.A.1.3.20 (1e-42)
(Continued )
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Table 2. (Continued)
Locus
tag
Conservationa Best match name Function(s) of best match Top blastp hit(s)b,c
BC2310 98.2 HsrA of Escherichia coli Unknown P31474 2.A.1.3.51 (4e-53); O32182 2.A.1.3.33 (2e-
47); O35018 2.A.1.3.30 (3e-44)
BC4497 79.3 TetA(L) of Bacillus subtilis Me2+tetracycline:2H+ antiporter P23054 2.A.1.3.16 (3e-46); P02983 2.A.1.3.6 (7e-
42); Q5PU79 2.A.1.3.22 (8e-25)
BC3349 91.1 MdtH of Escherichia coli Norfloxacin/enoxacin resistance P69367 2.A.1.2.21 (9e-30); O34546 2.A.1.2.69 (7e-
11); P0A0J7 2.A.1.2.10 (2e-11)
2.A.1.21—The Drug:H+ Antiporter-3 (12 Spanner) (DHA3) Family
BC5071 39.6 MefE of Streptococcus
pneumoniae
Macrolide efflux Q7BKK4 2.A.1.21.22 (8e-52); P95827 2.A.1.21.1
(1e-50); O31561 2.A.1.31.3 (1e-19)
BC2055 98.2 YjbB of Bacillus subtilis Unknown O31600 2.A.1.21.13 (5e-42)
BC1621 82.8 TIGR00900 of Bacillus clausii Putative macrolide exporter Q5WAS7 2.A.1.21.8 (6e-32); O31561 2.A.1.31.3
(2e-28); P39642 2.A.1.21.5 (2e-18)
BC1753 84.0 TetV of Mycobacterium
smegmatis
Tetracycline resistance O31137 2.A.1.21.3 (4e-25); C3WVU9 2.A.1.62.2
(4e-17); Q0E7C5 2.A.1.38.2 (1e-16)
BC4929 96.4 TetV of Mycobacterium
smegmatis
Tetracycline resistance O31137 2.A.1.21.3 (1e-23); O31561 2.A.1.31.3 (6e-
17); A8YZ14 2.A.1.62.1 (2e-17)
BC2411 83.4 MefE of Streptococcus
pneumoniae
Macrolide efflux Q7BKK4 2.A.1.21.22 (2e-23); P95827 2.A.1.21.1
(5e-21); C3WVU9 2.A.1.62.2 (3e-20)
BC2515 63.9 MFS porter of Stackebrandtia
nassauensis
Unknown D3Q871 2.A.1.21.11 (4e-21); O31561 2.A.1.31.3
(1e-20); Q55937 2.A.1.31.2 (1e-20)
BC0434* 98.2 TetV of Mycobacterium
smegmatis
Tetracycline resistance O31137 2.A.1.21.3 (4e-19); O31561 2.A.1.31.3 (2e-
17); Q9X4X4 2.A.1.30.1 (3e-13)
BC3225 83.4 MFS carrier of Thermoplasma
acidophilum
Unknown Q9HLP1 2.A.1.21.9 (3e-17); Q9X4X4 2.A.1.30.1
(4e-14); Q55937 2.A.1.31.2 (3e-13)
BC2325 1.2 MefA of Streptococcus
pyogenes
Macrolide efflux P95827 2.A.1.21.1 (1e-08); Q7BKK4 2.A.1.21.22
(9e-07)
2.A.1.26—The Unknown Major Facilitator-2 (UMF2) Family
BC3310* 99.4 YfkF of Bacillus subtilis Possible drug exporter O34929 2.A.1.26.2 (2e-126); P21503 2.A.1.26.1
(7e-16); Q56RY7 2.A.1.2.38 (1e-09)
2.A.1.31—The Nickel Resistance (Nre) Family
BC2450 42.0 KrsE of Bacillus cereus Kurstakin/surfactin exporter ortholog J8GQQ7 2.A.1.31.4 (0); O31561 2.A.1.31.3 (4e-38);
O31137 2.A.1.21.3 (7e-15)
BC1681* 97.6 YfiS of Bacillus subtilis Unknown O31561 2.A.1.31.3 (1e-27); C3WVU9 2.A.1.62.2
(1e-24); Q7BKK4 2.A.1.21.22 (3e-21)
BC2970 97.0 NrsD of Synechocystis
PCC6803
Ni2+ resistance protein Q55937 2.A.1.31.2 (2e-20); O31137 2.A.1.21.3 (7e-
16); Q7BKK4 2.A.1.21.22 (2e-14)
BC2894* 97.6 YfiS of Bacillus subtilis Unknown O31561 2.A.1.31.3 (2e-18); Q5WAS7 2.A.1.21.8
(6e-13); P95827 2.A.1.21.1 (1e-12)
BC2610 97.6 YfiS of Bacillus subtilis Unknown O31561 2.A.1.31.3 (2e-17); Q5WGH2 2.A.1.62.3
(7e-15); C3WVU9 2.A.1.62.2 (2e-12)
2.A.1.32—The Putative Aromatic Compound/Drug Exporter (ACDE) Family
BC5372 100.0 YfmO of Bacillus subtilis Putative copper/multidrug efflux O06473 2.A.1.32.3 (8e-83); Q54806 2.A.1.3.5 (1e-
18); P0A0J7 2.A.1.2.10 (1e-18)
2.A.1.35—The Fosmidomycin Resistance (Fsr) Family
BC1762 95.9 Fsr of Escherichia coli Fosmidomycin, trimethoprim and
CCCP
P52067 2.A.1.35.1 (3e-97); Q56877 2.A.1.35.2 (1e-
78); F8IC89 2.A.1.35.3 (5e-22)
2.A.1.36—The Acriflavin-sensitivity (YnfM) Family
BC3162 54.4 YgaY of Escherichia coli Unknown P76628 2.A.1.36.3 (1e-72); A8GHT9 2.A.1.36.2 (2e-
54); Q9ADP8 2.A.1.36.4 (5e-34)
2.A.1.46—The Unknown Major Facilitator-5 (UMF5) Family
BC0804 98.8 MFS porter of Bacillus cereus Putative quinolone resistance C2UR80 2.A.1.46.5 (0); B8GFY3 2.A.1.46.4 (2e-26);
P0A0J7 2.A.1.2.10 (3e-16)
(Continued )
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not cause a decrease in antimicrobial resistance [40], possibly because blt has a low basal
expression level and is not induced by antimicrobial substrates [16]. In addition to antimicro-
bials, the Blt multidrug efflux pump in B. subtilis is thought to have a physiological role in poly-
amine transport since the blt gene is encoded adjacent to a polyamine acetyltransferase gene
and appears to promote the efflux of spermidine [41]. In contrast, the BC0855 gene is not
encoded adjacent to a polyamine acetyltransferase gene, but is in a small cluster that also
includes the SMR family transport protein genes BC0852 and BC0853 (see below), and a TetR
family regulator gene BC0854. A partially palindromic sequence motif is conserved upstream
of the BC0855 pump, the BC0854 regulator and the BC0852/BC0853 SMR pump genes with
consensus: 5’-AAAaTGAxTGAtAGTCAtTCA-3’ (capital letters are in all three upstream
regions, lower case in two and x is different in all). This may be a binding site for a regulatory
protein, possibly that encoded by BC0854. Indeed, it was seen that in B. anthracis mutations in
the orthologous regulator gene and/or its promoter region appeared to be responsible for dere-
pression of all genes in the orthologous cluster. The increased expression of the transporter
genes may have been responsible for ciprofloxacin resistance in B. anthracis [42]. A similar
sequence (5’-AAAATAATTGACAGTCATTCA-3’) is found approximately 50 nt upstream of
a putative biotin biosynthetic gene cluster (BC4120-BC4114) in the B. cereus ATCC 14579
genome, however, the relevance of this is unknown.
ATP-binding cassette superfamily efflux pumps encoded in B. cereus
ATCC 14579
Similar to the MFS the ABC superfamily of transport proteins is large and ancient, and ubiqui-
tous to all classes of living organisms. In bacteria ABC superfamily pumps promote a range of
both efflux and uptake transport reactions with substrates that include metabolites, vitamins,
amino acids, lipids, peptides, ions and drugs. ABC superfamily pumps have been associated
with drug resistance in bacteria and the cells of higher organisms, such as human cancer cells.
The representative B. cereus group isolates examined in this work, B. anthracis Ames, B. cereus
ATCC 14579 and B. thuringensis konkukian 97–27, each encoded between 28 and 35 ABC
superfamily efflux pumps.
Table 2. (Continued)
Locus
tag
Conservationa Best match name Function(s) of best match Top blastp hit(s)b,c
BC2283 92.9 MFS porter of Bacillus cereus Putative quinolone resistance C2UR80 2.A.1.46.5 (4e-104); B8GFY3 2.A.1.46.4
(6e-24); P0A0J7 2.A.1.2.10 (4e-19)
BC3314 100.0 MFS porter of Bacillus cereus Putative quinolone resistance C2UR80 2.A.1.46.5 (2e-79); B8GFY3 2.A.1.46.4
(1e-21); P37621 2.A.1.46.7 (1e-18)
2.A.1.62—The Unidentified Major Facilitator-11 (UMF11) Family
BC2673 85.8 P-MEP of Fusobacterium
sp. 7_1
Putative Macrolide efflux, possibly
amino acid transport
C3WVU9 2.A.1.62.2 (2e-24); P95827 2.A.1.21.1
(2e-23); Q7BKK4 2.A.1.21.22 (2e-21)
BC2230* 94.1 UMF11 of Staphylococcus
aureus
Unknown A8YZ14 2.A.1.62.1 (1e-18); P95827 2.A.1.21.1 (9e-
08); P64783 2.A.1.21.12 (3e-07)
BC3197 12.4 P-MEP of Fusobacterium
sp. 7_1
Putative Macrolide efflux, possibly
amino acid transport
C3WVU9 2.A.1.62.2 (7e-15); D3Q871 2.A.1.21.11
(6e-11); Q55937 2.A.1.31.2 (1e-11)
a. Numbers show the percent conservation of the protein in the predicted proteomes of 169 B. cereus group isolates according to comparative BLASTP
searches (see Fig 1).
b. Uniprot accession numbers, TCDB accession numbers (boldface font) and e-values (in parentheses) for the top three blastp hits (e-value < 1e-5)
c. Blast hits for each family are in descending order of e-value for top hit
* genes marked with an asterisk were targeted by qRT-PCR analyses, see text for details.
https://doi.org/10.1371/journal.pone.0176188.t002
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Comparisons of the ABC superfamily pumps identified in B. cereus ATCC 14579 with those
in the TCDB using BLASTP identified several putative efflux systems that were closely related
to previously characterised drug efflux pumps (e-value = 0; Table 3). These included two
pumps that were similar to the YheI/YheH heterodimeric ABC superfamily multidrug efflux
pump in B. subtilis, renamed as BmrC/BmrD [43, 44]; BC0870/BC0871 (65%/64% identity and
82%/80% similarity to the BmrC/BmrD), BC3679/BC3678 (48%/45% identity, 66%/67% simi-
larity to BmrC/BmrD). In B. subtilis expression of BmrC/BmrD is responsive to ribosome-tar-
geting antibiotics, and is controlled by a transcriptional attenuation mechanism that involves
stem-loop structures upstream of bmrC, as well as a leader peptide BmrB which is encoded on
the same transcript as bmrC/bmrD [45]. BC0870/BC0871 is most closely related to bmrC/
bmrD in B. cereus ATCC 14579. BC0870 expression is also highly transcriptionally responsive
to several ribosome targeting antibiotics (see below). The region upstream of BC0870 in B.
cereus ATCC 14579 also contains sequences that could form stable stem-loop structures that
may facilitate a similar mode of regulation in this strain. However, no clear homolog of BrmB
is encoded in this region, highlighting a need for future experiments to investigate the regula-
tion of BC0870/BC0871 in B. cereus group isolates.
Three other ABC efflux systems identified in B. cereus ATCC 14579 were also closely related
to previously characterised drug efflux pumps listed in the TCDB and may function in drug
efflux. These include, BC1955 (63% identity, 78% similarity to BmrA of Bacillus subtilis),
BC0509 (59% identity, 78% similarity to Sav1866 of Staphylococcus aureus), and BC2371/
BC2372 (45%/46% identity, 66%/66% similarity to TM287/TM288 of Thermotoga maritima).
The transporter encoded by BC3590/BC3591 is orthologous to the BerA/BerB transport
system of B. thuringensis (95%/99% Identity, 97%/99% similarity), which has been linked to β-
exotoxin production/efflux [46]. The organisation of genes adjacent to BC3590/BC3591 is
identical in B. cereus ATCC 14579 and the β-exotoxin producing strain B. thuringiensis 407–1
[47]. Therefore, the regulation of BC3590/BC3591 in B. cereus ATCC 14579 may be similar to
berA/berB in B. thuringiensis. However, B. cereus ATCC 14579 does not produce β-exotoxin,
so the function of the pump encoded by BC3590/BC3591 is unknown. Genes encoding BerA/
BerB orthologs are conserved in 97.6–99.4% of B. cereus group isolates (Fig 1B; Table 3), there-
fore this ABC pump may have a core physiological function, potentially playing a fortuitous
role in β-exotoxin transport in strains that produce this toxin.
Resistance/nodulation/division superfamily efflux pumps encoded in B.
cereus ATCC 14579
Transport proteins classified within the RND superfamily of efflux pumps facilitate the
efflux of diverse substrates including antimicrobials, metals and lipids. Specialised RND
pumps within the SecDF family form accessory components of the Sec-translocase and thus
participate in protein secretion. In Gram-negative bacteria most RND pumps that mediate
small molecule transport are thought to form complexes with membrane fusion proteins
and outer-membrane proteins that allow substrates to be captured within the periplasm or
outer leaflet of the inner-membrane and transported across the outer-membrane. For
example, the periplasmic head domain in the AcrB RND pump from E. coli docks with the
TolC outer-membrane protein and the AcrA membrane fusion protein to move substrates
across the outer-membrane [48]. It remains to be demonstrated whether RND pumps are
able to capture substrates from within the bacterial cytoplasm. Since Gram-positive bacteria
do not have an outer-membrane, the substrates and molecular transport mechanisms of
Gram-positive RND efflux pumps, such as those encoded by strains within the B. cereus
group, are of particular interest.
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Table 3. Putative B. cereus ATCC 14579 ABC efflux pumps.
Locus
tag
Conservationa Best match name Function(s) of best
match
Localisationb Top blastp hit(s)c
3.A.1.105: The Drug Exporter-1 (DrugE1) Family
BC1734 100.0 ABC2 of Bacillus cereus Unknown C J8ABC0 3.A.1.105.9 (2e-101); Q9A0K0 3.
A.1.105.7 (7e-93); Q7UE58 3.A.1.105.8 (1e-67)
BC1735 99.4 SagGHI (Firmicutes) May export
streptolysin S
M Q9A0J9 3.A.1.105.7 (1e-37); J7ZHK9 3.
A.1.105.9 (1e-13); J8A8S6 3.A.1.105.9 (1e-8)
BC1736 97.6 SagGHI (Firmicutes) May export
streptolysin S
M Q9A0J8 3.A.1.105.7 (1e-51); J7ZHK9 3.
A.1.105.9 (3e-34); J8A8S6 3.A.1.105.9 (1e-15)
BC2478 94.1 ABC2 of Bacillus cereus Unknown C J8ABC0 3.A.1.105.9 (4e-63); Q3Z8A8 3.
A.1.105.6 (6e-62); Q4VWC9 3.A.1.105.4 (3e-56)
BC2479 93.5 ABC-2 of Dehalococcoides
ethenogenes
Unknown M Q3Z8A7 3.A.1.105.6 (3e-54); P0AFP9 3.
A.1.105.15 (5e-15); Q4VWC7 3.A.1.105.4 (6e-
13)
BC3435 98.8 OleC5 of Streptomyces
antibioticus
Drug resistance M Q53717 3.A.1.105.2 (3e-31); P32011 3.
A.1.105.1 (2e-28); Q9F2Y7 3.A.1.105.13 (3e-22)
BC3436 98.8 OleC4 of Streptomyces
antibioticus
Drug resistance C Q53716 3.A.1.105.2 (1e-75); Q9F2Y8 3.
A.1.105.13 (3e-74); P32010 3.A.1.105.1 (6e-71)
3.A.1.106: The Lipid Exporter (LipidE) Family
BC0509* 100.0 Sav1866 of Staphylococcus
aureus
Multidrug
resistance
MC Q2G2M9 3.A.1.106.2 (0); Q8G7R7 3.A.1.106.3
(1e-120); Q9WYC4 3.A.1.135.5 (4e-120)
BC0870* 100.0 YheI of Bacillus subtilis Multidrug
resistance
MC O07550 3.A.1.106.8 (0); P77265 3.A.1.106.13
(1e-162); A7VN01 3.A.1.106.5 (2e-154)
BC0871 68.6 YheH of Bacillus subtilis Multidrug
resistance
MC O07549 3.A.1.106.8 (0); P0AAG5 3.A.1.106.13
(1e-123); A7VN02 3.A.1.106.5 (8e-113)
BC3678 98.8 YheH of Bacillus subtilis Multidrug
resistance
MC O07549 3.A.1.106.8 (9e-164); Q9WYC4 3.
A.1.135.5 (1e-142); A7VN02 3.A.1.106.5 (5e-
133)
BC3679 99.4 YheI of Bacillus subtilis Multidrug
resistance
MC O07550 3.A.1.106.8 (0); P77265 3.A.1.106.13
(0); A7VN01 3.A.1.106.5 (0)
BC5182* 97.0 Sav1866 of Staphylococcus
aureus
Multidrug
resistance
MC Q2G2M9 3.A.1.106.2 (8e-127); Q8G7R7 3.
A.1.106.3 (5e-112); Q9WYC4 3.A.1.135.5 (4e-
111)
3.A.1.117: The Drug Exporter-2 (DrugE2) Family
BC1955 94.7 BmrA of Bacillus subtilis Multidrug
resistance
MC O06967 3.A.1.117.3 (0); P97046 3.A.1.117.1
(5e-162); O32748 3.A.1.117.2 (9e-162)
3.A.1.122: The Macrolide Exporter (MacB) Family
BC0764 77.5 ABC transporter of
Methanocaldococcus jannaschii
Unknown C Q58206 3.A.1.122.14 (3e-67); O31711 3.
A.1.122.2 (1e-64); Q8RKC1 3.A.1.122.3 (8e-64)
BC0814 100.0 YknZ of Bacillus subtilis Antimicrobial
peptide
M O31712 3.A.1.122.2 (2e-73); A0ZUB1 3.
A.1.122.12 (2e-48); P75831 3.A.1.122.1 (6e-48)
BC0815 99.4 YknY of Bacillus subtilis Antimicrobial
peptide
C O31711 3.A.1.122.2 (5e-107); Q58206 3.
A.1.122.14 (8e-76); Q8RKC1 3.A.1.122.3 (1e-
73)
BC3222 98.2 HrtA of Staphylococcus aureus Probable Heme
exporter
C Q7A3X3 3.A.1.122.4 (8e-63); Q58206 3.
A.1.122.14 (6e-59); A8TDW7 3.A.1.122.7 (9e-
59)
BC3223 99.4 HrtB of Corynebacterium
diphtheriae
Hemin resistance M H2GZC4 3.A.1.122.11 (4e-28); Q8TM31 3.
A.1.122.6 (2e-7)
BC5253 99.4 YknZ of Bacillus subtilis Antimicrobial
peptide
M O31712 3.A.1.122.2 (3e-109); A0ZUB1 3.
A.1.122.12 (6e-59); P75831 3.A.1.122.1 (9e-46)
BC5254 98.8 YknY of Bacillus subtilis Antimicrobial
peptide
C O31711 3.A.1.122.2 (4e-99); Q58206 3.
A.1.122.14 (7e-85); A8TDW7 3.A.1.122.7 (2e-
75)
3.A.1.124: The 3-component Peptide-5 Exporter (Pep5E) Family
(Continued )
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Table 3. (Continued)
Locus
tag
Conservationa Best match name Function(s) of best
match
Localisationb Top blastp hit(s)c
BC4221 94.1 SboF of Streptococcus salivarius Salivaricin exporter C Q09II0 3.A.1.124.5 (1e-40); Q75V15 3.A.1.124.3
(5e-38); Q45404 3.A.1.124.2 (1e-36)
3.A.1.126: The β-Exotoxin I Exporter (βETE) Family
BC3590 97.6 BerB of Bacillus thuringiensis Exporter of β-
exotoxin I
M Q8RME0 3.A.1.126.1 (2e-175)
BC3591 99.4 BerA of Bacillus thuringiensis Exporter of β-
exotoxin I
C Q8RME1 3.A.1.126.1 (0); H8I779 3.A.1.132.8
(3e-47); P42332 3.A.1.131.1 (8e-47)
3.A.1.132: The Gliding Motility ABC Transporter (Gld) Family
BC2902 83.4 ABC-2 of Streptococcus pyogenes Unknown C Q99ZC8 3.A.1.132.6 (1e-31); Q8RME1 3.
A.1.126.1 (1e-29); O30489 3.A.1.132.1 (1e-28)
3.A.1.134: The Peptide-7 Exporter (Pep7E) Family
BC2543 98.2 YxdL of Bacillus subtilis Peptide/multidrug C P42423 3.A.1.134.6 (8e-120); O06980 3.
A.1.134.5 (6e-115); Q8Y5F0 3.A.1.134.12 (5e-
97)
BC2544 68.0 YxdM of Bacillus subtilis Peptide/multidrug M P42424 3.A.1.134.6 (4e-116); O06981 3.
A.1.134.5 (9e-72); Q8Y5E9 3.A.1.134.12 (7e-50)
BC4823 21.3 AnrB of Listeria monocytogenes Multidrug
resistance
M Q8Y5E9 3.A.1.134.12 (7e-141); Q8VUH1 3.
A.1.134.2 (2e-61); O34741 3.A.1.134.3 (5e-61)
BC4824 0.0d AnrA of Listeria monocytogenes Multidrug
resistance
C Q8Y5F0 3.A.1.134.12 (4e-65); O06980 3.
A.1.134.5 (2e-52); O34697 3.A.1.134.3 (2e-50)
BC4830 99.4 AnrB of Listeria monocytogenes Multidrug
resistance
M Q8Y5E9 3.A.1.134.12 (2e-150); O06981 3.
A.1.134.5 (3e-64); O34741 3.A.1.134.3 (8e-64)
BC4831 99.4 AnrA of Listeria monocytogenes Multidrug
resistance
C Q8Y5F0 3.A.1.134.12 (5e-125); O34697 3.
A.1.134.3 (1e-98); O06980 3.A.1.134.5 (1e-95)
3.A.1.135: The Drug Exporter-4 (DrugE4) Family
BC2371 98.2 TM287 of Thermotoga maritima Unknown MC Q9WYC3 3.A.1.135.5 (1e-175); B8ZPJ9 3.
A.1.135.4 (8e-137); G9CHY8 3.A.1.135.3 (4e-
136)
BC2372 98.8 TM288 of Thermotoga maritima Unknown MC Q9WYC4 3.A.1.135.5 (0); B8ZPD1 3.A.1.135.4
(1e-145); Q8G7R7 3.A.1.106.3 (3e-145)
3.A.1.141: The Ethyl Viologen Exporter (EVE) Family (DUF990 Family)
BC0513 100.0 EvrA of Synechocystis sp.
PCC6803
Ethyl viologen
export
C P73329 3.A.1.141.1 (2e-85); Q8R6Q4 3.
A.1.141.2 (1e-65); P46903 3.A.1.115.1 (5e-48)
BC0514 98.2 AbcB of Thermoanaerobacter
tengcongensis
Unknown M Q8R6Q5 3.A.1.141.2 (6e-21)
BC0515 100.0 EvrC of Synechocystis sp.
PCC6803
Ethyl viologen
export
M P74757 3.A.1.141.1 (2e-14); Q8R6Q6 3.
A.1.141.2 (9e-6);
3.A.1.147:
BC3328 96.4 Exporter of Natranaerobius
thermophilus
Unknown M B2A6N2 3.A.1.147.5 (2e-9); J7IPE5 3.
A.1.147.10 (4e-9); C9XJW9 3.A.1.147.6 (9e-8)
BC3329 100.0 Exporter of Clostridium difficile Unknown C C9XJX0 3.A.1.147.6 (3e-88); C1A6K8 3.
A.1.147.1 (3e-75); B8ZKM9 3.A.1.147.8 (1e-74)
No clear family
BC1357 100.0 ABC-2 of Streptococcus pyogenes Unknown C Q99ZC8 3.A.1.132.6 (7e-68); P46903 3.
A.1.115.1 (5e-30); Q2SDB1 3.A.1.132.4 (5e-29)
BC1358 20.7 NA NA no significant hits
BC1359* 100.0 SboF of Streptococcus salivarius Salivaricin exporter C Q09II0 3.A.1.124.5 (4e-65); P42332 3.A.1.131.1
(1e-62); Q75V15 3.A.1.124.3 (2e-60)
BC1360 100.0 NA NA no significant hits
BC2719 7.7 SboF of Streptococcus salivarius Salivaricin exporter C Q09II0 3.A.1.124.5 (3e-56); Q75V15 3.A.1.124.3
(3e-55); P42332 3.A.1.131.1 (1e-50)
BC2720 7.7 no significant hits
(Continued )
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The genome of B. cereus ATCC 14579 encodes four RND superfamily transporters,
BC0714, BC1291, BC4405 and BC5435. One of these proteins, BC4405, has been studied previ-
ously by members of our team and shown to encode the SecDF component of the Sec-translo-
case [49]. BLASTP and phylogenetic analyses conducted here confirmed the relationship of
BC4405 and other SecDF RND proteins within the SecDF family (TCDB 2.A.6.4) (Table 4).
The functions of the remaining three RND proteins in B. cereus ATCC 14579 are unknown,
but may involve drug efflux (Table 1). Each of these proteins is highly conserved in at least
Table 3. (Continued)
Locus
tag
Conservationa Best match name Function(s) of best
match
Localisationb Top blastp hit(s)c
BC3665 70.4 NA NA no significant hits
BC3666 66.9 SboF of Streptococcus salivarius Salivaricin exporter C Q09II0 3.A.1.124.5 (1e-69); A6MER5 3.
A.1.124.4 (2e-64); Q75V15 3.A.1.124.3 (2e-62)
BC4533 100.0 NA NA no significant hits
BC4535 96.4 NA NA no significant hits
BC4537 100.0 BcrA of Bacillus licheniformis bacitracin
resistance
C P42332 3.A.1.131.1 (3e-94); Q09II0 3.A.1.124.5
(1e-68); Q75V15 3.A.1.124.3 (2e-65)
BC5284 97.0 PltJ of Pseudomonas sp. M18 Polyketide efflux M Q4VWC8 3.A.1.105.4 (3e-6)
BC5285* 100.0 ABC2 #2 of Methanocella
arvoryzae
Unknown C Q0W8T7 3.A.1.144.2 (8e-56); J8ABC0 3.
A.1.105.9 (7e-53); Q0W8T4 3.A.1.144.1 (3e-52)
BC5399 100.0 NatB of Rhodopirellula baltica Na extrusion
(putative)
M Q7UQ82 3.A.1.115.2 (1e-7); Q7NL24 3.
A.1.132.10 (5e-6);
BC5400 100.0 BcrA of Bacillus licheniformis Bacitracin
resistance
C P42332 3.A.1.131.1 (7e-80); Q09II0 3.A.1.124.5
(2e-69); H8I779 3.A.1.132.8 (4e-67)
BC5431 31.4 NA NA no significant hits
BC5433* 100.0 CmpA of Clostridium hathewayi Drug transport M Q83XH1 3.A.1.121.4 (1e-54); P43672 3.
A.1.120.6 (3e-54); Q60248 3.A.1.120.4 (2e-47)
a. Numbers show the percent conservation of the protein in the predicted proteomes of 169 B. cereus group isolates according to comparative BLASTP
searches (see Fig 1).
b. Localization, M: transmembrane domain, C: cytoplasmic ATP-binding domain, MC: fused membrane and cytoplasmic domains.
c. Uniprot accession numbers, TCDB accession numbers (boldface font) and e-values (in parentheses) for the top three blastp hits (e-value < 1e-5).
d. BC4824 is annotated as a pseudogene, and is thus not associated with a protein coding sequence.
* genes marked with an asterisk were targeted by qRT-PCR analyses, see text for details.
https://doi.org/10.1371/journal.pone.0176188.t003
Table 4. Putative B. cereus ATCC 14579 RND efflux pumps.
Locus
tag
Conservationa Best match name Function(s) of best match Top blastp hit(s)b
BC_0714 96.4 YerP of Bacillus subtilis Surfactin export D4G632 2.A.6.3.9 (0); Q8CX78 2.A.6.3.6 (6e-128);
B4WH09 2.A.6.3.5 (4e-116)
BC_1291 100.0 MmpL3 of Mycobacterium
tuberculosis
Trehalose monomycolate
export
O53657 2.A.6.5.6 (2e-77); P65374 2.A.6.5.5 (3e-35);
Q53902 2.A.6.5.1 (3e-34)
BC_4405 100.0 SecDF of Bacillus subtilis Protein translocation O32047 2.A.6.4.2 (0); Q5SKE6 2.A.6.4.3 (3e-102); P0AG90
2.A.6.4.1 (2e-43)
BC_5435 99.4 YerP of Bacillus subtilis Surfactin export D4G632 2.A.6.3.9 (0); Q8CX78 2.A.6.3.6 (7e-149);
Q1DEX6 2.A.6.3.4 (2e-135)
a. Numbers show the percent conservation of the protein in the predicted proteomes of 169 B. cereus group isolates according to comparative BLASTP
searches (see Fig 1).
b. Uniprot accession numbers, TCDB accession numbers (boldface font) and e-values (in parentheses) for the top three blastp hits (e-value < 1e-5).
https://doi.org/10.1371/journal.pone.0176188.t004
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96% of sequenced representatives in the B. cereus group (Table 4; Fig 1), suggesting an impor-
tant core function (Table 4).
BLASTP and phylogenetic analyses showed that the BC0714 and BC5435 pumps should be
classified as members of the putative nodulation factor exporter (NFE) family (TCDB 2.A.6.3)
and are most closely related to YerP from B. subtilis (Table 4). Functional analyses of YerP
recently demonstrated that overexpression of this pump in its native host resulted in increased
secretion of endogenously produced surfactin into the supernatant [37]. YerP is also known to
be involved in surfactin resistance in strains that do not produce an endogenous surfactin and
can mediate resistance to acriflavine and ethidium [50]. Amphiphilic substrates such as surfac-
tin, acriflavine or ethidium could be present in the outer-leaflet of the cytoplasmic membrane
in Bacillus species and be stripped from this location by an RND pump, then expelled into the
environment. Similar to YerP, BC0714 and BC5435 may recognise an endogenous substrate. A
noteworthy feature of the BC5435 sequence was the presence of an extended periplasmic loop
in the region corresponding to the TolC docking domain of the structurally characterised
AcrB pump (S1 Fig). An extended loop is also present in the B. subtilis YerP protein, but not in
any of the other RND proteins currently listed in TCDB. The loop in BC5435 is glutamine, ser-
ine and alanine-rich which may be important for function, possibly playing a role in substrate
release given the putative location of the loops near the substrate exit site.
The fourth RND pump encoded by B. cereus ATCC 14579, BC1291, fell within the (Gram-
positive bacterial putative) hydrophobe/amphiphile efflux-2 (HAE2) family (TCDB 2.A.6.5)
clade (Table 4). Most of the characterised pumps in this family transport lipids or cell wall
components. With respect to proteins listed in the TCDB, BC1291 is most related to MmpL3
and MmpL11 from Mycobacterium tuberculosis, which transport mycobacterial specific cell
wall components (Table 4). The YdfJ system encoded in B. subtilis is also a member of the
HAE2 family. A deletion mutant of this pump did not show increased susceptibility to a panel
of more than 31 antimicrobials [51]. Therefore, these pumps may not have any cross-specific-
ity for drugs.
Small multidrug resistance family efflux pumps encoded in B. cereus
ATCC 14579
The SMR family is classified within the drug/metabolite superfamily, which also includes fami-
lies of pumps that mediate the export or uptake of a range of sugars, amino acids and other
metabolites. Transporters classified within the SMR family are the smallest known efflux
pumps that have been characterised to date. A complete SMR transport system consists of two
polypeptides, each approximately 110 amino acids in length, and can be homo- or heterodi-
meric. There are three putative SMR family transport systems encoded in the genome of B.
cereus ATCC 14579. Two of these pumps, BC0852/BC0853 and BC4213/BC4214, are predicted
to function as heterodimers, since they are each encoded by two adjacent genes. These two sys-
tems are homologous to the B. subtilis YkkCD system (Table 5). The complete YkkCD trans-
porter is a multidrug efflux pump that confers resistance to a range of antibiotics and biocides
[52]. As mentioned above BC0852/BC0853 are encoded near the blt homolog BC0855 in the B.
cereus genome and are likely to be under similar regulatory control to this pump. The third
SMR efflux pump encoded by B. cereus ATCC 14579, BC0358, is likely to function as a homo-
logomer and is most related to NepA of Arthrobacter nicotinovorans (37% identity, 55% simi-
larity), part of the NepAB efflux pump, and the staphylococcal QacC pump (35% identity, 63%
similarity). The NepAB system is predicted to export methylamine [53], whereas QacC is a
prototypical member of the SMR family and confers resistance to a range of cationic biocides
[54].
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Multidrug and toxic compound extrusion family efflux pumps encoded in
B. cereus ATCC 14579
The MATE family of multidrug efflux pumps is one of 31 families classified within the multi-
drug/oligosaccharidyl-lipid/polysaccharide flippase superfamily. Transport proteins classified
within the MATE family are ubiquitous to all classes of living organisms and are energised by
secondary energy sources, including the proton- or sodium-motive-force. The genome of B.
cereus ATCC 14579 encodes four putative MATE family efflux pumps, BC1184, BC1383,
BC1615 and BC1716, each of which is conserved in more than 98% of the B. cereus group
strains to have had their genome sequences determined (Fig 1). None of the B. cereus ATCC
14579 MATE pumps have been functionally characterised. The pump encoded by BC1716 is
very similar (75% identity, 89% similarity) to the putative multidrug efflux system, YoeA from
B. subtilis (Table 6). The pump encoded by BC1615 is related to DinF from Bacillus halodurans
(31% identity, 56% similarity). DinF is multidrug efflux pump that was recently characterised
by X-ray crystallography, providing details of the substrate binding site and proton coupling
mechanism [55]. The BC1615 pump may also act as a multidrug efflux pump and recognise
similar substrates to DinF, including the antimicrobial dyes ethidium and rhodamine 6G [55].
Table 6. Putative B. cereus ATCC 14579 MATE efflux pumps.
Locus
tag
Conservationa Best match name Function(s) of best
match
Top blastp hit(s)b
BC1184 99.4 NorM of Thermotoga maritima Probable multidrug
resistance
Q9WZS2 2.A.66.1.28 (8e-44); P76352 2.A.66.1.23 (2e-37);
D5CJ69 2.A.66.1.22 (5e-32)
BC1383 98.2 PdrM of Streptococcus
pneumoniae
Multidrug efflux Q8DPQ6 2.A.66.1.41 (1e-100); Q9I3Y3 2.A.66.1.12 (2e-97);
O82855 2.A.66.1.1 (5e-95)
BC1615 98.8 DinF-like pump of Bacillus
halodurans
Multidrug efflux Q9KAX3 2.A.66.1.32 (1e-67); Q7WZ38 2.A.66.1.37 (2e-64);
Q93HR7 2.A.66.1.7 (3e-50)
BC1716 98.8 YoeA of Bacillus subtilis Probable multidrug
resistance
O34474 2.A.66.1.25 (0); Q2G140 2.A.66.1.13 (3e-33); I6L8P4 2.
A.66.1.33 (4e-33)
a. Numbers show the percent conservation of the protein in the predicted proteomes of 169 B. cereus group isolates according to comparative BLASTP
searches (see Fig 1).
b. Uniprot accession numbers, TCDB accession numbers (boldface font) and e-values (in parentheses) for the top three blastp hits (e-value < 1e-5).
https://doi.org/10.1371/journal.pone.0176188.t006
Table 5. Putative B. cereus ATCC 14579 SMR efflux pumps.
Locus
tag
Conservationa Best match name Function(s) of best
match
Top blastp hit(s)b
BC0358 92.9 NepA of Arthrobacter
nicotinovorans
probably exports
methylamine
Q8GAI5 2.A.7.1.8 (2e-20); P14319 2.A.7.1.1 (6e-20); Q2FD83
2.A.7.1.11 (1e-18)
BC0852 93.5 YkkC of Bacillus subtilis Multidrug efflux P49856 2.A.7.1.5 (1e-14); D5CES3 2.A.7.1.10 (2e-13); P69937
2.A.7.1.4 (3e-12)
BC0853 92.3 YkkD of Bacillus subtilis Multidrug efflux P49857 2.A.7.1.5 (7e-21); D5CES3 2.A.7.1.10 (3e-20); P69937
2.A.7.1.4 (1e-17)
BC4213 88.2 YkkC of Bacillus subtilis Multidrug efflux P49856 2.A.7.1.5 (4e-27); D5CES3 2.A.7.1.10 (1e-22); P69937
2.A.7.1.4 (3e-21
BC4214 95.3 YkkD of Bacillus subtilis Multidrug efflux P49857 2.A.7.1.5 (4e-32); D5CES3 2.A.7.1.10 (4e-27); P69937
2.A.7.1.4 (6e-25)
a. Numbers show the percent conservation of the protein in the predicted proteomes of 169 B. cereus group isolates according to comparative BLASTP
searches (see Fig 1).
b. Uniprot accession numbers, TCDB accession numbers (boldface font) and e-values (in parentheses) for the top three blastp hits (e-value < 1e-5).
https://doi.org/10.1371/journal.pone.0176188.t005
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Large scale qRT-PCR analyses to examine potential physiological
functions of efflux pumps in B. cereus ATCC 14579
To experimentally characterise the efflux functions of pumps identified in our in silico analy-
ses, we have constructed a number of gene deletion mutants. To date we have made targeted
deletions in three genes encoding MFS pumps, BC4707 [23], BC3310 [33] and BC4000, all
four genes encoding RND pumps, BC 0714, BC1291, BC4405 [49] and BC5435, as well as
BC1360 and BC0852, which encode components of an ABC pump and an SMR pump, respec-
tively. The construction of B. cereus gene deletion mutants is labour intensive and this work
identified drug resistance phenotypes for only two of the targeted pumps [23, 33], possibly
because of functional redundancy between sub-sets of pumps encoded in B. cereus, due to
overlapping substrate specificities. Furthermore, a loss-of-function screen for reduced biofilm
formation among deletion mutants in transporters included in this study identified BC4405 as
the only transporter with an identifiable phenotype (S2 Fig), in line with the role of SecDF in
protein secretion, and the importance of cell surface proteins in B. cereus group biofilm forma-
tion [56]. To assess the potential transport functions of putative efflux systems in B. cereus with
increased throughput, we adopted an alternative approach based on gene expression.
Most efflux pumps are only required by bacterial cells at specific times, e.g., when their sub-
strates reach a threshold level in the cell, and the uncontrolled expression of efflux pumps at
other times could reduce cellular fitness. Consequently, efflux pump expression can be tightly
controlled in response to substrate or substrate-related environmental stress conditions. This
inducible regulatory control offers a potential mechanism to gain insight into the core physio-
logical functions of efflux pumps by evaluating transcriptional responses to putative substrates
by qRT-PCR. To this end, we evaluated the expression of 30 efflux system genes in B. cereus
ATCC 14579 after exposure to a panel of nine antimicrobials or stress conditions. The efflux
systems tested included all three SMR family (Table 5), all four MATE family (Table 6) and all
four RND superfamily (Table 4) pumps identified in this strain, as well as, 13 MFS (Table 2)
and six ABC superfamily pumps (Table 3).
Of the eight compounds tested, five were antibiotics belonging to different drug classes that
are likely to be transported by efflux pumps, i.e., chloramphenicol, norfloxacin, kanamycin,
erythromycin and tetracycline. The antimicrobial dye ethidium bromide was included as it is a
common substrate for multidrug efflux pumps. The iron-chelating compound 2,2’-dipyridyl
(DIP) was included to promote iron limitation and highlight efflux systems that may be
involved in iron homeostasis. Tannic acid, a polyphenolic plant derived compound was
included as an environmental compound with antimicrobial properties. Finally, an extract
from the cuticle of the common paper wasp Polistes humilis, shown to have antimicrobial
activity [24], was included. This wasp extract is likely to contain a mixture of antimicrobial
compounds produced by the insect to provide microbial defence. The susceptibility of B. cereus
ATCC 14579 towards the compounds was determined (S3 Table), and the cells treated with
concentrations 50% of their respective minimum inhibitory concentrations (MIC).
We conducted hierarchical clustering to identify compounds that induced similar expres-
sion responses among the genes, and conversely sub-sets of genes that showed similar patterns
of expression in response to the different antimicrobials (Fig 2). These analyses indicated that
the antibiotics, particularly kanamycin, erythromycin, chloramphenicol and tetracycline,
induced similar changes in gene expression. Tannic acid and DIP also induced a similar pat-
tern of induction across the genes tested, whereas, the gene expression changes induced by
ethidium bromide were distinct from the other compounds (Fig 2).
The plant-derived polyphenolic compound tannic acid induced the expression of a number
of putative efflux pump genes. As seen from our clustering analyses the gene expression changes
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Fig 2. Gene expression changes in response to antimicrobial and environmental shock treatments.
Relative efflux pump gene expression levels were examined using qRT-PCR on RNA extracted from B. cereus
ATCC 14579 treated with antimicrobial compounds compared with untreated cells. B. cereus ATCC 14579
cells were grown at 30˚C in MH broth to OD600 = 0.8 and then treated for 20 minutes with the antimicrobial
compounds chloramphenicol, norfloxacin, kanamycin, erythromycin, tetracycline, ethidium bromide, 2,2’-
dipyridole, tannic acid and wasp extract, at concentrations corresponding to 50% of the MIC (S3 Table). The
BC1744 helicase gene was used as the reference gene to normalize the data. Hierarchical clustering analysis
[57] was performed on the average gene expression values using the Pearson correlation method using the
TIGR Multi-Experiment Viewer TMEV software [58]. The scale shows log2 fold-changes in gene expression
between treated cells and untreated controls.
https://doi.org/10.1371/journal.pone.0176188.g002
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induced by DIP were similar to those of tannic acid, but not as strong. DIP is a strong iron-che-
lator, and at least some of the antimicrobial properties of tannic acid are known to stem from its
capacity for iron chelation [59]. Therefore, the overlapping expression changes induced by
these compounds are most likely to be related to iron limitation in the media. A small set of
genes was strongly induced by both of these compounds (Fig 2). Norfloxacin, which may also
bind to metal ions [60], also caused low-level induction of the genes in this group. Most promi-
nent among the genes induced by iron limitation was BC5182, which encodes an ABC pump
similar to the S. aureus multidrug efflux pump Sav1866 (Table 3). In light of its induction by
DIP and tannic acid, BC5182 may have a role in iron uptake. In line with this hypothesis a puta-
tive binding site for the ferric uptake regulator (Fur) was identified 40 nt upstream of the gene.
The sequence of this Fur box (TGATAATGGTTATCA) is an almost perfect match to the Fur
box sequence identified in B. subtilis [61]. The gene encoding the SecDF system, BC4405, was
also weakly but specifically induced by tannic acid and DIP, which may reflect a need for the
cell to re-organise its membrane protein content during iron-limitation.
Some genes, including the MFS gene BC4000 and the RND pump BC0714, appeared to be
upregulated as a response to most or all of the tested conditions, although the strongest
changes in expression were induced by different compounds (Fig 2). These genes may be regu-
lated as part of general stress responses and could encode multidrug efflux pumps. The trans-
porter encoded by BC4000 is a member of the DHA2 family of the MFS and is closely related
to the characterized multidrug efflux system Bmr3 of B. subtilis, strengthening the hypothesis
that this protein functions in multidrug efflux. Interestingly, the MFS efflux system encoded
by BC4707, which is also closely related to Bmr3 and was recently shown to function as a mul-
tidrug exporter [23] was not highly induced by any of the compounds tested. Expression of
this pump was induced by bile salts, but based on expression signals from this gene in both
microarray data and qRT-PCR this gene is not constitutively expressed at a high level in B.
cereus [32]. Therefore the BC4707 transport protein may have additional physiological func-
tions that are unrelated to drug efflux.
A number of putative efflux pump genes were responsive to tetracycline and chloramphenicol
exposure and fell into a single large group that may include antibiotic efflux systems (Fig 2).
Many of these genes were also induced by tannic acid, albeit to a lesser extent than tetracycline
(Fig 2). Notably, all three SMR family pumps, BC0358, BC0852 and BC4213 fell within this antibi-
otic induced group of genes and display very similar patterns of induction by the nine treatments
(Fig 2). The MFS pump BC0855 was also similarly responsive to the treatments. As mentioned
above genes encoding the SMR pump BC0852 and MFS pump BC0855 are preceded by a con-
served palindromic sequence that could function as a binding site for a regulatory element. A sim-
ilar sequence was not present in the upstream regions of the other two SMR genes or other
similarly regulated genes, suggesting these genes are under the control of distinct regulatory ele-
ments. The largest transcriptional response, giving an approximately thirty-fold increase in
expression compared with the untreated control, was observed for the BC0870 in response to tet-
racycline. BC0870 was also induced by more than ten-fold in response to chloramphenicol and
by approximately three-fold in response to erythromycin. This is in line with the induction of its
B. subtilis ortholog, yheI (bmrC), by ribosome targeting antibiotics (see discussion of the BC0870
promoter region above), however, kanamycin did not induce high expression.
The insect gut has been postulated to constitute a natural habitat for B. cereus group bacteria
[4]. Thus, transcriptional responses for the above described transporters were analysed follow-
ing exposure of B. cereus ATCC 14579 to insect antimicrobial compounds in a crude ethanol
surface extract of a social paper wasp, Polistes humilis [24]. The putative ABC-transporter
ATP-binding protein BC1359, which had only shown a minor response upon exposure to the
other antimicrobial compounds tested (Fig 2), was the only pump gene showing strong
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expression induction by wasp extract exposure (>20-fold induction). BC1359 is encoded in a
cluster of four genes that each encode an ABC transporter component (BC1357-BC1360).
BC1357 and BC1359 encode nucleotide-binding domains that are most similar to ABC-2 of
Streptococcus pyogenes and SboF of Streptococcus salivarius, respectively (Table 3). These nucle-
otide-binding domains may function with proteins encoded by BC1358 and BC1360 that each
have six predicted transmembrane helices, to produce a complete transporter with 12 trans-
membrane helices and two nucleotide binding domains, similar to well-characterised ABC
family pumps catalysing efflux. However, BC1358 and BC1360 do not display any significant
similarity to characterised efflux pumps listed in the TCDB (Table 3). Additionally, the
BC1358 gene is not highly conserved across the B. cereus group (20.7% conservation; Table 3),
so may be dispensable or replaceable in many strains.
Based on RNA sequencing data from orthologs in B. cereus ATCC 10987, the
BC1356-BC1360 cluster is likely to be co-transcribed in an operon [62]. An expanded
qRT-PCR analysis of the BC1356-BC1360 locus showed that all genes were more than 19-fold
upregulated following exposure to the wasp extract (S4 Table). MIC-studies further showed
that Proteinase K treatment (37˚C, 1 h) abolished antimicrobial activity at the maximum con-
centration of wasp extract available. Polistes dominulus has been shown to synthesize two anti-
microbial peptides present on the cuticle and in the venom, Dominulin A and B, respectively
[63]. A qRT-PCR experiment investigating the transcriptional response of the
BC1356-BC1360 genes following exposure of B. cereus ATCC 14579 to custom synthesized
Dominulin B at a concentration corresponding to 50% of its MIC value (S3 Table), showed
that all genes in the locus were induced more than 26-fold (S4 Table). Interestingly this pres-
ents a novel B. cereus group transporter locus which is conserved across sequenced isolates and
responds to one or more antimicrobial peptides from an insect source. This pump could con-
stitute a case of export proteins potentially contributing to resistance to insect-derived antimi-
crobial peptides, a resistance type which has previously largely been attributed to alanylation
of negatively charged teichoic acids by the dlt locus [64].
Conclusions
Using the TransAAP we demonstrated that bacterial strains within the B. cereus group may
devote more than 2.5% of their protein coding potential to the production of drug efflux
pumps (Table 1). This represents one of the largest investments in efflux potential of any bacte-
rial lineage. We have only just begun to unravel the functions associated with these many efflux
systems. However, most pumps were highly conserved across the B. cereus group (Fig 1), sug-
gesting that they mediate core functions that may be common to different species occupying a
variety of niches. We suspect that a number of the efflux pumps encoded by members of the B.
cereus group are able to mediate the efflux of drugs, either as a core function or fortuitously.
However, due to their large numbers we have found that the characterisation of these pumps
by gene deletion analyses is challenging. The work described here has highlighted putative
functions for a number of pumps that warrant future focussed investigations in a heterologous
system or using purified protein. For example, the BC5182 ABC pump is likely to play a role in
iron homeostasis, possibly by the efflux of a siderophore, whereas BC4000 and BC0714 may
represent novel multidrug efflux pumps, and the BC1357-BC1360 pump may confer resistance
to antimicrobial peptides. We are particularly interested in the functional mechanisms and
modes of operation of the RND superfamily pumps, such as BC0714. In Gram-negative bacte-
ria RND efflux pumps are likely to capture their substrates from the periplasm and transport
them across the outer membrane, however, their functional roles and mechanisms of transport
in Gram-positive bacteria are largely unknown.
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Supporting information
S1 Fig. Amino acid sequence alignment of BacillusRND efflux proteins with the prototypi-
cal RND transporter AcrB from E. coli. The amino acids composing a loop likely to represent
the exit site for substrates from AcrB (into TolC) is marked by a red box.
(TIFF)
S2 Fig. Biofilm formation of B. cereus ATCC 14579 wild type and the isogenic ΔsecDF dele-
tion mutant measured in a microplate screening assay after 48h and 72h growth. (A) Bars
represent the mean of four independent experiments and error bars represent the standard
deviation. The B. cereus ATCC 14579 wild type is shown in dark grey and the ΔsecDF mutant
in light grey. The single star symbolizes P< 0.05 and double stars symbolize P < 0.005 in a
two-tailed paired t-test. (B) Pictures show dye-stained biofilms of wild type B. cereus ATCC
14579 (B1) and ΔsecDF (B2) strains after 48 h growth. Displayed is a top-down view of the
wells, which shows a strong effect of secDF deletion on the submerged part of the biofilm at the
bottom of the wells. Visually there was no difference in biofilm mass between the wild type
and the ΔsecDF mutant for biofilm formed in the air-liquid-interface.
(TIFF)
S1 Table. Bacillus cereus group strains used for comparative analyses of B. cereus ATCC
14579 efflux pumps. A complete list of the 168 B. cereus group strains used in comparative
analyses of efflux pumps, along with the RefSeq accession numbers of their genome sequences.
(DOCX)
S2 Table. List of primers used in the current study. The names and nucleotide sequences of
all primers used in the current study.
(DOCX)
S3 Table. Susceptibility of B. cereus ATCC 14579 towards compounds used in antimicro-
bial exposure experiments. The minimum inhibitory concentrations of the compound used
in transcriptional analyses against B. cereus ATCC 14579.
(DOCX)
S4 Table. Expression induction of genes BC1356-BC1360 in response to wasp surface etha-
nol extract and Dominulin B. Relative expression of the BC1356-BC1360 gene cluster follow-
ing to wasp surface ethanol extract and the antimicrobial peptide Dominulin B.
(DOCX)
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